Business Description
GeNeuro SA
ISIN : CH0308403085
Compare
Compare
Traded in other countries / regions
GNRO.FranceGEM.GermanyGNROp.UK IPO Date
2016-04-21Description
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.02 | |||||
9-Day RSI | 48.38 | |||||
14-Day RSI | 47.46 | |||||
3-1 Month Momentum % | -10.67 | |||||
6-1 Month Momentum % | -13.55 | |||||
12-1 Month Momentum % | -77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GeNeuro SA Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.59 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.13 | ||
| 3-Year Sortino Ratio | -0.21 | ||
| Volatility % | 139.03 | ||
| 14-Day RSI | 47.46 | ||
| 14-Day ATR (€) | 0.00041 | ||
| 20-Day SMA (€) | 0.0268 | ||
| 12-1 Month Momentum % | -77 | ||
| 52-Week Range (€) | 0.02 - 0.127 | ||
| Shares Outstanding (Mil) | 29.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GeNeuro SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GeNeuro SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
GeNeuro SA Frequently Asked Questions
What is GeNeuro SA(FRA:GEM)'s stock price today?
The current price of FRA:GEM is €0.03. The 52 week high of FRA:GEM is €0.13 and 52 week low is €0.02.
When is next earnings date of GeNeuro SA(FRA:GEM)?
The next earnings date of GeNeuro SA(FRA:GEM) is .
Does GeNeuro SA(FRA:GEM) pay dividends? If so, how much?
GeNeuro SA(FRA:GEM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on GeNeuro SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers